Aktiv Pharma Group to Participate in the FDA Emerging Technology Progr

todaySeptember 26, 2022

Broomfield, CO (PRWEB) September 26, 2022

Aktiv Pharma Group (Aktiv) announced today the acceptance of its novel glass-free, film-based flexible primary drug container (PDC) technology for steril

Written by:

Rate it

Previous post

Similar posts

Post comments (0)

Leave a reply

Your email address will not be published. Required fields are marked *

IMPACTFest Global